Literature DB >> 3136820

Comparison of the efficacy of "Trisdine" and kanamycin-colistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord trauma.

J W Pearman1, M Bailey, W E Harper.   

Abstract

An open, prospective, randomised, comparative study of "Trisdine" and kanamycin-colistin bladder instillations in reducing significant bacteriuria during intermittent urethral catheterisation was conducted. Trisdine is an aqueous solution of chlorhexidine gluconate 0.01% with added ethylenediaminetetra-acetic acid disodium salt and TRIS buffer at final concentrations of 1.34 mMoles and 0.01 Molar respectively. All patients (15 males and 3 females) admitted with acute spinal cord trauma and bladder involvement requiring intermittent catheterisation for more than 5 days during a 12-month period were studied. There was no significant difference in the mean incidence of significant bacteriuria during intermittent catheterisation in the 7 males who had kanamycin-colistin bladder instillations compared with the 8 males who had Trisdine instillations. A comparison could not be made in the females because there were only 3 patients. Because Trisdine is more stable at ambient temperatures, is less likely to select antibiotic-resistant bacteria and is less expensive, it is concluded that Trisdine is preferable to kanamycin-colistin solution for bladder instillations during intermittent catheterisation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3136820     DOI: 10.1111/j.1464-410x.1988.tb04293.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  8 in total

Review 1.  Catheter-associated infections: pathogenesis affects prevention.

Authors:  Barbara W Trautner; Rabih O Darouiche
Journal:  Arch Intern Med       Date:  2004-04-26

2.  Management of urinary tract infection with intravesical amikacin may increase the risk of bladder oxidative stress in children with neurogenic bladder.

Authors:  Akin Soner Amasyali; Dilek Yilmaz; Mustafa Yilmaz; Faruk Kucukdurmaz; Ferah Sonmez; Haluk Erol
Journal:  Int Urol Nephrol       Date:  2017-09-27       Impact factor: 2.370

3.  Potentiation of the in vitro activity of some antimicrobial agents against selected gram-negative bacteria by EDTA-tromethamine.

Authors:  A M Farca; P Nebbia; G Re
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

Review 4.  Colistin bladder instillation, an alternative way of treating multi-resistant Acinetobacter urinary tract infection: a case series and review of literature.

Authors:  R Giua; C Pedone; L Cortese; R Antonelli Incalzi
Journal:  Infection       Date:  2013-07-25       Impact factor: 3.553

Review 5.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 6.  Role of biofilm in catheter-associated urinary tract infection.

Authors:  Barbara W Trautner; Rabih O Darouiche
Journal:  Am J Infect Control       Date:  2004-05       Impact factor: 2.918

Review 7.  Recurrent urinary tract infections in patients with incomplete bladder emptying: is there a role for intravesical therapy?

Authors:  Elizabeth V Dray; J Quentin Clemens
Journal:  Transl Androl Urol       Date:  2017-07

Review 8.  Are Intravesical Aminoglycosides the New Gold Standard in the Management of Refractory Urinary Tract Infection: A Systematic Review of Literature.

Authors:  Andrea Ong; Amelia Pietropaolo; George Brown; Bhaskar K Somani
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.